A cost-effectiveness analysis of telemedicine and mobile health interventions to support continuing care

The ISSUP activities funded by the U.S. Department of State are temporarily suspended.
This website will remain live, but ISSUP is not currently monitoring or updating it. No new membership applications will be accepted or reviewed, no posts or comments will be possible, and members cannot login.
This information will be updated with any change in circumstances. Thank you for your understanding.

Back to Telehealth / Telesalud main page

Andrew Quanbeck, PhD
University of Wisconsin-Madison

Abstract
This presentation reports the cost-effectiveness analysis from a fully powered randomized clinical trial that featured a head-to-head comparison between telemedicine and digital health interventions for providing continuing care for patients with alcohol use disorder. A telemedicine intervention (telephone monitoring and counseling: TMC) and a mobile health intervention (Alcohol Comprehensive Health Enhancement Support System: A-CHESS) were examined in a 2x2 factorial randomized trial that enrolled 262 participants from two Philadelphia area intensive outpatient programs. Intervention costs and effectiveness (in terms of number of risky drinking days) were assessed for each group with respect to the control group.